Skip to Content
Due to a recent surge in pediatric RSV and flu, we are allowing only visitors 18 years of age and older in our general inpatient (hospital) settings at this time for the safety of our patients, in line with Illinois Department of Public Health guidance. Read More

Sarcoma Cancer Trials

​A091902: A Multicenter Phase II Trial of Paclitaxel with and without Nivolumab in Taxane Naive, and Nivolumab and Cabozantinib in Taxane Pretreated Subjects with Angiosarcoma
Aims: The purpose of this study is to see the good and bad effects of adding  Nivolumab immunotherapy to Taxol chemotherapy.
Diagnosis: angio-sarcoma
Principal Investigator: Bruce Brockstein, MD
IRB Approval Number: EH20-414
Sponsor: Alliance for Clinical Trials in Oncology
Contact: Interested patients should contact research nurse Michele Britto, RN at 847.570.2109
Open to Enrollment: Yes

 

Ayala AL-DES-01: A Phase 2/3, Randomized, Multicenter Study to Evaluate AL 102 in Paitents iwth Progressing Desmoid Tumors
Aims: The purpose of this study is to see the good and bad effects of using the investigational drug called AL102 to treat desmoid tumors.
Diagnosis: Desmoid tumors
Principal Investigator: Bruce Brockstein, MD
IRB Approval Number: EH21-180
Sponsor: Ayala Pharmaceuticals, Inc.
Contact: Interested patients should contact research nurse Michele Britto, RN at 847.570.2109
Open to Enrollment: Yes